Stryker Net Worth
Stryker Net Worth Breakdown | SYK |
Stryker Net Worth Analysis
Stryker's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Stryker's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Stryker's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Stryker's net worth analysis. One common approach is to calculate Stryker's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Stryker's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Stryker's net worth. This approach calculates the present value of Stryker's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Stryker's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Stryker's net worth. This involves comparing Stryker's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Stryker's net worth relative to its peers.
Enterprise Value |
|
To determine if Stryker is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Stryker's net worth research are outlined below:
| Stryker generated a negative expected return over the last 90 days | |
| Stryker is unlikely to experience financial distress in the next 2 years | |
| Over 80.0% of the company shares are owned by institutional investors | |
| On 31st of January 2025 Stryker paid $ 0.84 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Parnassus Investments LLC Sells 142,911 Shares of Stryker Co. |
Stryker Quarterly Good Will |
|
Stryker uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Stryker. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Stryker's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 30th of January 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 30th of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Stryker Target Price Consensus
Stryker target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Stryker's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 32 | Strong Buy |
Most Stryker analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Stryker stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Stryker, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationStryker Target Price Projection
Stryker's current and average target prices are 369.53 and 408.49, respectively. The current price of Stryker is the price at which Stryker is currently trading. On the other hand, Stryker's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Stryker Market Quote on 16th of March 2025
Target Price
Analyst Consensus On Stryker Target Price
Know Stryker's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Stryker is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stryker backward and forwards among themselves. Stryker's institutional investor refers to the entity that pools money to purchase Stryker's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of New York Mellon Corp | 2024-12-31 | 5.4 M | Fundsmith Llp | 2024-12-31 | 5.3 M | Norges Bank | 2024-12-31 | 4.8 M | Fisher Asset Management, Llc | 2024-12-31 | 4.1 M | Northern Trust Corp | 2024-12-31 | 3.6 M | Franklin Resources Inc | 2024-12-31 | 3.5 M | First Western Trust Bank | 2024-12-31 | 3.5 M | Bank Of America Corp | 2024-12-31 | 3 M | Mackenzie Investments | 2024-12-31 | 2.8 M | Vanguard Group Inc | 2024-12-31 | 32.7 M | Blackrock Inc | 2024-12-31 | 26.8 M |
Follow Stryker's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 141 B.Market Cap |
|
Project Stryker's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.10 | |
| Return On Capital Employed | 0.10 | 0.10 | |
| Return On Assets | 0.07 | 0.11 | |
| Return On Equity | 0.15 | 0.19 |
When accessing Stryker's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Stryker's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Stryker's profitability and make more informed investment decisions.
Evaluate Stryker's management efficiency
Stryker has Return on Asset of 0.0747 % which means that on every $100 spent on assets, it made $0.0747 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1526 %, implying that it generated $0.1526 on every 100 dollars invested. Stryker's management efficiency ratios could be used to measure how well Stryker manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Stryker's Return On Assets are quite stable compared to the past year. Return On Equity is expected to rise to 0.19 this year, although the value of Return On Tangible Assets will most likely fall to 0.10. At this time, Stryker's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 45.1 B this year, although the value of Non Current Liabilities Other will most likely fall to about 1.8 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 54.16 | 56.87 | |
| Tangible Book Value Per Share | 1.01 | 0.96 | |
| Enterprise Value Over EBITDA | 23.61 | 13.16 | |
| Price Book Value Ratio | 6.65 | 6.39 | |
| Enterprise Value Multiple | 23.61 | 13.16 | |
| Price Fair Value | 6.65 | 6.39 | |
| Enterprise Value | 111.3 B | 116.9 B |
The strategic vision of Stryker management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Enterprise Value Revenue 6.6435 | Revenue | Quarterly Revenue Growth 0.107 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stryker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stryker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Stryker insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Spencer Stiles over six months ago Acquisition by Spencer Stiles of 8499 shares of Stryker subject to Rule 16b-3 | ||
Yin Becker over six months ago Acquisition by Yin Becker of 3060 shares of Stryker at 339.77 subject to Rule 16b-3 | ||
Ramesh Subrahmanian over a year ago Payment of 2378 shares by Ramesh Subrahmanian of Stryker subject to Rule 16b-3 |
Stryker Corporate Filings
F4 | 12th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 19th of February 2025 Other Reports | ViewVerify | |
| 13th of February 2025 Other Reports | ViewVerify |
Stryker Earnings Estimation Breakdown
The calculation of Stryker's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Stryker is estimated to be 2.7368 with the future projection ranging from a low of 2.65 to a high of 3.14. Please be aware that this consensus of annual earnings estimates for Stryker is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
2.65 Lowest | Expected EPS | 3.14 Highest |
Stryker Earnings Projection Consensus
Suppose the current estimates of Stryker's value are higher than the current market price of the Stryker stock. In this case, investors may conclude that Stryker is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Stryker's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 32 | 95.9% | 4.01 | 2.7368 | 7.76 |
Stryker Earnings History
Earnings estimate consensus by Stryker analysts from Wall Street is used by the market to judge Stryker's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Stryker's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Stryker Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Stryker's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Stryker Earnings per Share Projection vs Actual
Actual Earning per Share of Stryker refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Stryker predict the company's earnings will be in the future. The higher the earnings per share of Stryker, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Stryker Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Stryker, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Stryker should always be considered in relation to other companies to make a more educated investment decision.Stryker Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Stryker's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-01-28 | 2024-12-31 | 3.87 | 4.01 | 0.14 | 3 | ||
2024-10-29 | 2024-09-30 | 2.77 | 2.87 | 0.1 | 3 | ||
2024-07-30 | 2024-06-30 | 2.79 | 2.81 | 0.02 | 0 | ||
2024-04-30 | 2024-03-31 | 2.35 | 2.5 | 0.15 | 6 | ||
2024-01-30 | 2023-12-31 | 3.27 | 3.46 | 0.19 | 5 | ||
2023-11-02 | 2023-09-30 | 2.43 | 2.46 | 0.03 | 1 | ||
2023-08-03 | 2023-06-30 | 2.38 | 2.54 | 0.16 | 6 | ||
2023-05-01 | 2023-03-31 | 2 | 2.14 | 0.14 | 7 | ||
2023-01-31 | 2022-12-31 | 2.84 | 3.0 | 0.16 | 5 | ||
2022-10-31 | 2022-09-30 | 2.23 | 2.12 | -0.11 | 4 | ||
2022-07-26 | 2022-06-30 | 2.28 | 2.25 | -0.03 | 1 | ||
2022-04-28 | 2022-03-31 | 1.95 | 1.97 | 0.02 | 1 | ||
2022-01-27 | 2021-12-31 | 2.72 | 2.71 | -0.01 | 0 | ||
2021-10-28 | 2021-09-30 | 2.28 | 2.2 | -0.08 | 3 | ||
2021-07-27 | 2021-06-30 | 2.13 | 2.25 | 0.12 | 5 | ||
2021-04-27 | 2021-03-31 | 1.99 | 1.93 | -0.06 | 3 | ||
2021-01-27 | 2020-12-31 | 2.55 | 2.81 | 0.26 | 10 | ||
2020-10-29 | 2020-09-30 | 1.41 | 2.14 | 0.73 | 51 | ||
2020-07-30 | 2020-06-30 | 0.55 | 0.64 | 0.09 | 16 | ||
2020-04-30 | 2020-03-31 | 1.69 | 1.84 | 0.15 | 8 | ||
2020-01-28 | 2019-12-31 | 2.46 | 2.49 | 0.03 | 1 | ||
2019-10-29 | 2019-09-30 | 1.9 | 1.91 | 0.01 | 0 | ||
2019-07-25 | 2019-06-30 | 1.94 | 1.98 | 0.04 | 2 | ||
2019-04-23 | 2019-03-31 | 1.84 | 1.88 | 0.04 | 2 | ||
2019-01-29 | 2018-12-31 | 2.15 | 2.18 | 0.03 | 1 | ||
2018-10-25 | 2018-09-30 | 1.68 | 1.69 | 0.01 | 0 | ||
2018-07-24 | 2018-06-30 | 1.73 | 1.76 | 0.03 | 1 | ||
2018-04-26 | 2018-03-31 | 1.6 | 1.68 | 0.08 | 5 | ||
2018-01-30 | 2017-12-31 | 1.95 | 1.96 | 0.01 | 0 | ||
2017-10-26 | 2017-09-30 | 1.5 | 1.52 | 0.02 | 1 | ||
2017-07-27 | 2017-06-30 | 1.51 | 1.53 | 0.02 | 1 | ||
2017-04-25 | 2017-03-31 | 1.43 | 1.48 | 0.05 | 3 | ||
2017-01-24 | 2016-12-31 | 1.76 | 1.78 | 0.02 | 1 | ||
2016-10-27 | 2016-09-30 | 1.37 | 1.39 | 0.02 | 1 | ||
2016-07-21 | 2016-06-30 | 1.37 | 1.39 | 0.02 | 1 | ||
2016-04-20 | 2016-03-31 | 1.2 | 1.24 | 0.04 | 3 | ||
2016-01-26 | 2015-12-31 | 1.55 | 1.56 | 0.01 | 0 | ||
2015-10-22 | 2015-09-30 | 1.23 | 1.25 | 0.02 | 1 | ||
2015-07-23 | 2015-06-30 | 1.17 | 1.2 | 0.03 | 2 | ||
2015-04-21 | 2015-03-31 | 1.08 | 1.11 | 0.03 | 2 | ||
2015-01-27 | 2014-12-31 | 1.45 | 1.44 | -0.01 | 0 | ||
2014-10-16 | 2014-09-30 | 1.14 | 1.15 | 0.01 | 0 | ||
2014-07-17 | 2014-06-30 | 1.08 | 1.08 | 0.0 | 0 | ||
2014-04-23 | 2014-03-31 | 1.08 | 1.06 | -0.02 | 1 | ||
2014-01-22 | 2013-12-31 | 1.22 | 1.23 | 0.01 | 0 | ||
2013-10-17 | 2013-09-30 | 0.99 | 0.98 | -0.01 | 1 | ||
2013-07-18 | 2013-06-30 | 1.03 | 1.0 | -0.03 | 2 | ||
2013-04-24 | 2013-03-31 | 1.01 | 1.03 | 0.02 | 1 | ||
2013-01-23 | 2012-12-31 | 1.12 | 1.14 | 0.02 | 1 | ||
2012-10-17 | 2012-09-30 | 0.98 | 0.97 | -0.01 | 1 | ||
2012-07-18 | 2012-06-30 | 0.99 | 0.98 | -0.01 | 1 | ||
2012-04-17 | 2012-03-31 | 0.99 | 0.99 | 0.0 | 0 | ||
2012-01-24 | 2011-12-31 | 1.02 | 1.02 | 0.0 | 0 | ||
2011-10-19 | 2011-09-30 | 0.89 | 0.91 | 0.02 | 2 | ||
2011-07-19 | 2011-06-30 | 0.9 | 0.9 | 0.0 | 0 | ||
2011-04-19 | 2011-03-31 | 0.89 | 0.9 | 0.01 | 1 | ||
2011-01-25 | 2010-12-31 | 0.91 | 0.93 | 0.02 | 2 | ||
2010-10-19 | 2010-09-30 | 0.77 | 0.8 | 0.03 | 3 | ||
2010-07-20 | 2010-06-30 | 0.8 | 0.8 | 0.0 | 0 | ||
2010-04-20 | 2010-03-31 | 0.78 | 0.8 | 0.02 | 2 | ||
2010-01-26 | 2009-12-31 | 0.82 | 0.82 | 0.0 | 0 | ||
2009-10-20 | 2009-09-30 | 0.69 | 0.69 | 0.0 | 0 | ||
2009-07-21 | 2009-06-30 | 0.72 | 0.73 | 0.01 | 1 | ||
2009-04-20 | 2009-03-31 | 0.71 | 0.71 | 0.0 | 0 | ||
2009-01-27 | 2008-12-31 | 0.74 | 0.74 | 0.0 | 0 | ||
2008-10-16 | 2008-09-30 | 0.67 | 0.66 | -0.01 | 1 | ||
2008-07-17 | 2008-06-30 | 0.73 | 0.73 | 0.0 | 0 | ||
2008-04-17 | 2008-03-31 | 0.69 | 0.7 | 0.01 | 1 | ||
2008-01-23 | 2007-12-31 | 0.66 | 0.66 | 0.0 | 0 | ||
2007-10-17 | 2007-09-30 | 0.55 | 0.55 | 0.0 | 0 | ||
2007-07-19 | 2007-06-30 | 0.61 | 0.61 | 0.0 | 0 | ||
2007-04-18 | 2007-03-31 | 0.58 | 0.59 | 0.01 | 1 | ||
2007-01-25 | 2006-12-31 | 0.55 | 0.55 | 0.0 | 0 | ||
2006-10-17 | 2006-09-30 | 0.46 | 0.46 | 0.0 | 0 | ||
2006-07-20 | 2006-06-30 | 0.51 | 0.52 | 0.01 | 1 | ||
2006-04-20 | 2006-03-31 | 0.48 | 0.49 | 0.01 | 2 | ||
2006-01-26 | 2005-12-31 | 0.48 | 0.48 | 0.0 | 0 | ||
2005-10-18 | 2005-09-30 | 0.41 | 0.4 | -0.01 | 2 | ||
2005-07-19 | 2005-06-30 | 0.44 | 0.45 | 0.01 | 2 | ||
2005-04-19 | 2005-03-31 | 0.4 | 0.42 | 0.02 | 5 | ||
2005-01-26 | 2004-12-31 | 0.4 | 0.4 | 0.0 | 0 | ||
2004-10-14 | 2004-09-30 | 0.33 | 0.33 | 0.0 | 0 | ||
2004-07-15 | 2004-06-30 | 0.34 | 0.37 | 0.03 | 8 | ||
2004-04-15 | 2004-03-31 | 0.31 | 0.33 | 0.02 | 6 | ||
2004-01-29 | 2003-12-31 | 0.33 | 0.33 | 0.0 | 0 | ||
2003-10-16 | 2003-09-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2003-07-15 | 2003-06-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2003-04-16 | 2003-03-31 | 0.24 | 0.26 | 0.02 | 8 | ||
2003-01-27 | 2002-12-31 | 0.25 | 0.26 | 0.01 | 4 | ||
2002-10-16 | 2002-09-30 | 0.18 | 0.21 | 0.03 | 16 | ||
2002-07-16 | 2002-06-30 | 0.2 | 0.21 | 0.01 | 5 | ||
2002-04-17 | 2002-03-31 | 0.2 | 0.2 | 0.0 | 0 | ||
2002-01-28 | 2001-12-31 | 0.2 | 0.2 | 0.0 | 0 | ||
2001-10-17 | 2001-09-30 | 0.15 | 0.15 | 0.0 | 0 | ||
2001-07-17 | 2001-06-30 | 0.16 | 0.16 | 0.0 | 0 | ||
2001-04-18 | 2001-03-31 | 0.16 | 0.16 | 0.0 | 0 | ||
2001-01-29 | 2000-12-31 | 0.16 | 0.17 | 0.01 | 6 | ||
2000-10-17 | 2000-09-30 | 0.13 | 0.13 | 0.0 | 0 | ||
2000-07-20 | 2000-06-30 | 0.13 | 0.13 | 0.0 | 0 | ||
2000-04-18 | 2000-03-31 | 0.13 | 0.13 | 0.0 | 0 | ||
2000-01-27 | 1999-12-31 | 0.13 | 0.13 | 0.0 | 0 | ||
1999-10-19 | 1999-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
1999-07-21 | 1999-06-30 | 0.09 | 0.1 | 0.01 | 11 | ||
1999-04-20 | 1999-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
1999-01-28 | 1998-12-31 | 0.11 | 0.11 | 0.0 | 0 | ||
1998-10-12 | 1998-09-30 | 0.09 | 0.09 | 0.0 | 0 | ||
1998-07-13 | 1998-06-30 | 0.09 | 0.09 | 0.0 | 0 | ||
1998-04-13 | 1998-03-31 | 0.09 | 0.09 | 0.0 | 0 | ||
1998-01-14 | 1997-12-31 | 0.09 | 0.1 | 0.01 | 11 | ||
1997-10-13 | 1997-09-30 | 0.08 | 0.08 | 0.0 | 0 | ||
1997-07-14 | 1997-06-30 | 0.08 | 0.08 | 0.0 | 0 | ||
1997-04-14 | 1997-03-31 | 0.08 | 0.08 | 0.0 | 0 | ||
1997-01-13 | 1996-12-31 | 0.08 | 0.08 | 0.0 | 0 | ||
1996-10-14 | 1996-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
1996-07-15 | 1996-06-30 | 0.06 | 0.06 | 0.0 | 0 | ||
1996-04-15 | 1996-03-31 | 0.06 | 0.07 | 0.01 | 16 |
Stryker Corporate Directors
| Andrew Silvernail | Independent Director | Profile | |
| Sherilyn McCoy | Independent Director | Profile | |
| Ronda Stryker | Independent Director | Profile | |
| Allan Golston | Lead Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.53) | Dividend Share 3.24 | Earnings Share 7.76 | Revenue Per Share | Quarterly Revenue Growth 0.107 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.